Tag: american association for clinical chemistry

December 2, 2013 “Intelligence: Late-Breaking Lab News”

Despite the continuing cutbacks in reimbursement for lab testing, some professional investors still see opportunity in this market sector. On November 13, Genova Diagnostics, Inc., of Asheville, North Carolina, was acquired by Levine Leichtman Capital Partners and “members of management.” The sellers were Nautic Partners and Ferrer Freeman & Company, LLC. Genova’s CEO is Ted

View Article

Staunch Laboratory Advocate Retires After 31 Years of Service

LAST MONTH, THE LABORATORY INDUSTRY lost one its most dedicated, full-time advocates. With his retirement in January, Joe Boone, Ph.D., ended a 31-year career with the Centers for Disease Control and Prevention (CDC).

Boone started with the CDC in 1977. In 1992, he assumed his present position as Associate Director for Science, Division of Laboratory Systems

View Article

July 28, 2008 “Intelligence: Late Breaking Lab News”

Last Monday, UroPath, Inc., an Arlington, Texas, company operating anatomic pathology laboratory condominium complexes in several states, disclosed its sale to HealthTronics, Inc., of Austin, Texas. Sales price was $7.75 million. UroPath’s former owners are urologists who founded the company in 2003. (See TDR, August 9, 2004.) HealthTronics sells and maintains lithotripters, laser products, and

View Article

2000’s Movers & Shakers Represent Strong Leaders

CEO SUMMARY: Its time again for THE DARK REPORT to make its yearly selection of the lab industry’s Movers & Shakers. Individuals chosen for 2000 represent a cross section of laboratory companies. Their successes demonstrate that leadership and vision continue to make a difference, despite the financial challenges of today’s healthcare marketplace.

IT IS ALWAYS A

View Article